G Csf
May 31, 2007 at 12:36
Feb 08, 2007 at 08:39
Feb 07, 2007 at 18:44
Jul 18, 2006 at 16:02
Photos »
/ 
Related News »
Noida, UP -- (SBWIRE) -- 05/17/2012 -- RNCOS has recently added a new Market Research Report titled, “G-CSF Biosimilars Market Forecast to 2015” to its report gallery. For the past few years, the biosimilars industry has been growing ...
May 18, 2012 at 03:26 | Source: SBWire
The Company's products now in clinical trials include an interferon alpha for treating Hepatitis C, and a G-CSF for treating neutropenia. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any ...
May 24, 2012 at 14:46 | Source: TMCnet
The "CSFassay-human B.1.0" product is capable of measuring 173 cerebrospinal fluid (CSF) proteins simultaneously that have been identified as likely biomarkers in various central nervous system (CNS) disorders. Barry McAleer, PhD, CEO of NextGen ...
May 17, 2012 at 10:58 | Source: San Francisco Gate
$22.7 million class G to 'Csf' from 'CCsf'; RE 0%; --$25.2 million class H to 'Csf' from 'CCsf'; RE 0%; --$4.3 million class O to 'Dsf' from 'Csf'; RE 0%. Fitch affirms the following classes as indicated: --$96.7 million class A-2 at 'AAAsf ...
May 11, 2012 at 15:37 | Source: Reuters
The Company's products now in clinical trials include an interferon alpha for treating Hepatitis C, and a G-CSF for treating neutropenia. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any ...
May 17, 2012 at 14:47 | Source: TMCnet
Kent was required to receive four straight days of Granulocyte Colony Stimulating Factor (G-CSF) injections, a hormone that stimulates bone marrow to produce stem cells in the blood stream. These cells grow and divide into red blood cells ...
May 21, 2012 at 23:54 | Source: The Post and Courier
Fitch downgrades the following classes and assigns Recovery Estimates (REs) as indicated: --$16.4 million class E to 'CCCsf' from 'B-sf'; RE 100%; --$20.5 million class F to 'Csf' from 'B-sf'; RE 10%; --$16.4 million class G to 'Csf' from 'CCsf ...
May 17, 2012 at 23:58 | Source: Boston Globe
Fitch affirms the following classes and revises Outlooks as indicated: --$1.7 million class F at 'BBB-sf'; Outlook to Stable from Negative; --$23.9 million class G at 'Csf'; RE 15%; --$5.5 million class H at 'Dsf'; RE 0%; --Class I at 'Dsf'; RE 0%.
May 10, 2012 at 17:26 | Source: StreetInsider.com
With Brava, documents are published in a secure content-sealed format (.csf). The proprietary format protects the ... and add file level security, e.g., expire the file after a configurable time period. See Figure 1. Figure 1: Brava file viewer ...
May 25, 2012 at 02:49 | Source: Law.com
About Maxygen Maxygen is a biotechnology company focused on the potential further development of its MAXY-G34 product candidate, a next-generation pegylated, granulocyte colony stimulating factor, or G-CSF, for the treatment of chemotherapy-induced ...
May 14, 2012 at 15:41 | Source: Emailwire